Epilepsy is often associated with reduced general intellectual functioning and specific cognitive impairments, such as general mental slowness, memory impairment and attention deficits ([@R1], [@R2]). Even though understanding of neuropsychological impairment in epilepsy has implications for the treatment and rehabilitation of this common disorder ([@R3], [@R4]), most of the earlier studies have carried out on determining the localization and lateralization of the epileptogenic abnormality in adult patients with focal epilepsy ([@R5]) and researchers have recently concentrated on the neuropsychological deficits in non-lesional, so-called idiopathic epilepsies ([@R3]). This aspect may provide clues concerning the underlying pathogenic process and the potential compensatory mechanisms that come into play ([@R3]). While the cognitive function of patients with Idiopathic Generalized Epilepsy (IGE) is usually within the normal range, they tend to be somewhat lower than in the general population ([@R6]-[@R8]). However we should always consider the negative impact of antiepileptic drugs on cognitive function of these patients who receive medications.

Juvenile Myoclonic Epilepsy (JME) is the most common form of IGE ([@R9]). Previous studies have shown neuropsychological deficits in patients with JME, affecting mainly frontal lobe functions, such as visual working memory, mental flexibility, concept formation, cognitive speed, executive functions mainly planning, perseveration, task switching, verbal fluency, and response inhibition ([@R10]-[@R15]). However, the presence of cognitive impairments and related factors in JME patients has not yet been thoroughly investigated despite the extensive literature on cognition in other types of epilepsy. Moreover, most studies on patients with epilepsy have not considered confounding factors such as depression in the neuropsychological evaluation.

The aim of this study was 1) to compare cognitive function in JME patients with sex, age and education-matched healthy controls using several neuropsychological tests and 2) to evaluate changes in cognitive function due to epilepsy and mentioned demographic variables in a sample of patients with JME in Iran.

Material and Methods {#s1}
====================

Thirty two consecutive patients with JME admitted at the epilepsy clinic of Sina Hospital, and 32 healthy controls in Tehran, Iran were enrolled in the study. JME was diagnosed using International League Against Epilepsy (ILAE) classification ([@R6]). Entry criteria for patients included normal brain MRI, age between 16-60 years, completion of primary school as the minimum level of education, juvenile onset of myoclonic jerks with or without generalized tonic-clonic seizure, generalized discharges of an irregular mixture of 3-6 Hz spike/polyspikes-slow waves on Electroencephalography (EEG). The exclusion criteria were the presence of an illness other than JME that may affect cognitive functions including neurological or psychiatric disorders, occurrence of a generalized seizure within the previous month or myoclonic jerks or absence seizures within the previous 24 hours, mental retardation (IQ score below 85 based on Raven's Progressive Matrices test), progressive psychiatric and neurological disorders, alcohol or drug abuse, ongoing use of any medications affecting central nervous system. Age-, sex- and education-matched healthy control subjects collected from patient's accompanies or other healthy subjects who were admitted to Sina hospital and had no medical, neurological or psychiatric illnesses, neither had family history of seizures and history of medication use which may affect cognitive function. Subjects in both groups signed their written informed consents prior to being included in this study.

JME diagnosis and EEG recording were done by an expert neurologist in the field of Epilepsy. Subjects completed a questionnaire including clinical and socio-demographic information as gender, age, level of education, duration of epilepsy, type and frequency of seizures, and drug treatment. Neuropsychological tests were administered in a sound-attenuated, temperature-controlled room by a single trained neurologist. General information, orientation, mental control, logical memory, forward and backward digit spans, visual memory, associative learning, and Memory Quotient (MQ) from the Persian version of Wechsler Memory Scale (WMS)-Revised were evaluated ([@R17]). The Wisconsin Card Sorting Test (WCST) perseverative errors was selected for evaluating executive function ([@R18]). Attention and control of inhibition evaluated using the Stroop Test (color and word) ([@R19]). IQ scores were obtained from Raven's Progressive Matrices test ([@R20]) and depression was evaluated using the Persian version of Beck Depression Inventory (BDI-II) (Cronbach's alpha = 0.87 and r = 0.73) ([@R21]).

Cognitive functions and depression between the JME and control groups were compared. In the JME group, we evaluated correlation between cognitive performance and age, sex, level of education, history of febrile convulsion, familial history of epilepsy, disease and medication history.

SPSS 11.0 (SPSS Inc, Chicago, Illinois, USA) software was used for statistical analysis. Student's t-test and the Mann-Whitney U-test were used for independent normally and non-normally distributed continuous variables, respectively. Nominal variables were analyzed by means of Chi square test. Correlation between neuropsychological scores, patient characteristics, and epilepsy variables was evaluated by Pearson's correlation analysis. Significance was defined at the level of p\<0.05.

Result {#s2}
======

The characteristics of 32 patients with JME and 32 controls has been compared in [Table 1](#T1){ref-type="table"}. There were no significant differences in age, gender, and level of education between the JME and control groups. Twenty one patients (65.6%) had a family history of epilepsy and six patients (18.8%) had experienced febrile convulsion. The duration of epilepsy and medication were 11.8±11.4 and 8.6±8.9 years, respectively. The proportions of patients who received valproate or topiramate were 21 (65.6%) and 1 (3.1%), respectively, and other patients received polytherapy (different combinations of valproate, topiramate, carbamazepine, phenytoein, phenobarbital, lamotrigine, and sodium valproate).

As shown in [Table 2](#T2){ref-type="table"}, patients with JME exhibit worse performances in more domains of cognitive functions compared to controls. However, significant differences were observed between JME and control groups with respect to scores of mental control (7.2±1.5 vs. 8.1±1.2, p=0.015), forward digit span (5.7±0.7 vs. 6.2 ±0.7, p=0.004), total digit span (9.8±1.1 vs. 10.6± 1.2, p=0.008), and IQ (106.7±11.8 vs. 115.8±11.8, p=0.003). Also, difference in Memory Quotient (MQ) value was significant between two groups in p\<0.06.

The patients with JME who graduated from the university had higher values of logical memory (11.0±3.4 vs. 8.5±4.3, p=0.015), visual memory (11.1±3.5 vs. 9.2±3.0, p=0.048), forward digit span (6.0±0.7 vs. 5.3±0.5, p=0.013), MQ (110.3±14.3 vs. 102.8±14.1, p=0.044), IQ (113.6±12.5 vs. 106.4±12.8, p=0.036), and lower value of Stroop color (1.8±1.8 vs. 3.8±2.1, p\<0.001) compared to other patients. However, there were not significant association between the scores of cognitive function tests and sex, history of febrile convulsion and familial history in the patients with JME.

There were significant correlation between age of patients with JME and scores of associative learning (r=-0.663, p\<0.001), perseverative errors (r=0.394, p=0.028), Stroop color (r=0.616, p\<0.001), and IQ (r=-0.530, p=0.002).

Duration of treatment and epilepsy had significant correlation with values of mental control (r=-0.574, p=0.001; r=-0.373, p=0.035), backward digit span (r=-0.475, p=0.006; r=-0.370, p=0.037), total digit span (r=-0.517, p=0.002; r=-0.359, p=0.044), associative learning (r=-0.395, p=0.025; r=-0.532, p=0.002), perseverative errors (r=0.446, p=0.012; r=0.437, p=0.014), Stroop color (r=0.782, p\<0.001; r=0.608, p\<0.001), and IQ (r=-0.603, p\<0.001; r=-0.535, p=0.002). Moreover, duration of treatment was correlated with scores of logical memory (r=-0.373, p=0.043) and forward digit span (r=-0.424, p=0.016). However, the poor performances in cognitive function tests in the JME group were not correlated with dose of antiepileptic medications.

Discussion {#s3}
==========

This study showed the presence of cognitive impairment in the patients with JME. The negative impact of JME is reflected in several cognitive domains including IQ, mental control, forward and total digit span, compared to the healthy controls, whereas mood and education level were similar in two groups. Moreover, age, level of education, duration of epilepsy and medication had an impact on several cognitive functions in the patients with JME.

Executive Functions {#s3a}
-------------------

Neuropsychological studies have shown that the deficits in the area of behavior, social adjustment and executive functions, which are observed in JME, point to frontal lobe involvement in this disorder ([@R3]). Dysfunction of these regions, especially the prefrontal cortex, results in disturbances in the organization and self-regulation of behavior. These functions involve in the elaboration of cognitive and behavioral responses and strategies for the attainment of immediate or future goals ([@R3], [@R22]). In addition, significant executive dysfunction in children with JME has been associated with significantly smaller thalamus and increased frontal cerebrospinal fluid ([@R14]). Thus, frontal and thalamic volumes appear to mediate the relationship between executive functioning and brain structure in patients with JME ([@R4]). The present study confirmed previous evidences for frontal lobe dysfunction in JME ([@R10], [@R11], [@R23]-[@R27]).

Intelligence Quotient (IQ): Some investigations have shown a decline in the intellectual function of IGE patients ([@R6]-[@R8], [@R28], [@R29]). In agreement with our results, Pascalicchio et al ([@R3]) found significantly lower IQ score in the patients with JME compared to controls, whereas some previous studies reported no significant differences in IQ score between these patients and control groups ([@R11], [@R23], [@R30]). Lower IQ scores were observed in the patients with a younger age at onset, more frequent seizures, more frequent episodes of Status Epilepticus, longer duration of seizure attacks, structural abnormalities in the brain and atypical absence seizures ([@R6], [@R22] and [@R31]). However, our results showed that the IQ scores of patients with JME had positive correlation with educational level and had negative correlation with age, disease duration and medication.

Level of Education {#s3b}
------------------

In agreement with several studies such as Pascalicchio et al ([@R12]), we could find a positive relationship between the level of education and higher scores in several cognitive domains in the patients with JME. The neuropsychological assessment of the patients with higher level of education (more than 16 years) showed significant preference in the scores of logical memory, visual memory, forward digit span, MQ and IQ compared to patients with lower level of education. However we could not find similar pattern in Stroop color test.

The implication of this difference might be an important finding for modification of cognitive deficits and its negative consequences on their quality of life. This can be done by encouraging the patients in schooling to promote educational achievement.

Considering the side effects of antiepileptic drugs on cognitive function, the basic neuropathology of seizure disorders including JME, it may not be possible to prevent cognitive deficits in all of the patients, therefore education could be a modifiable variable for more resistance against cognitive deficits in these patients.

Digit Span {#s3c}
----------

This test evaluates attention, short-term memory and working memory capacity. We found significant differences between patients with JME and controls in respect to forward and total digit span score which was in consistent with two previous studies ([@R7], [@R30]). However, Sonmez et al ([@R23]) reported no signiffcant difference in the digit span test between patients with JME and control groups. They found the digit span scores of patients with a familial history of seizures were lower than patients without this. Our results showed that this test could be influenced by the level of education, disease duration and medication. One of the justifications of our results may be explained by the known side effects of antiepileptic medications on concentration and memory.

Visual Memory and Visuospatial Function: Sonmez et al. ([@R23]) found impaired visual memory and visuospatial function in the patient with JME, which were in contrast to our results and Kim study ([@R30]). Also, they reported a significant difference between two groups on Stroop test. These differences might be attributable to the lack of assessment of depression in the study of Sonmez et al; hence their study does not exclude the effect of depressed mood on global cognitive performance. On the other hand, we found deficit in mental control in the patients with JME which was not reported in the previous studies.

Disease Duration {#s3d}
----------------

Duration of the epilepsy was correlated with cognitive performance, which confirmed in two previous studies ([@R7], [@R30]). Evidence suggests that prolonged exposure to abnormal neural activity during a critical period of cerebral maturation may disrupt the structural and functional changes in the brain that contribute to the establishment of the neural substrate for language development, learning and lateralization of functions ([@R3]). However, the results of our study are not compatible with Somnez et al ([@R23]) which did not find such correlation in their series of JME patients. In addition, there was significant correlation between duration of medication use and cognitive function or alternatively, it may be due to duration of disease. Most antiepileptic drugs (AEDs), such as topiramate, have the potential to exert detrimental effects on cognitive function. However, the small percentage of our patients (3.1%) has been on topiramate and 21 patients (65.6%) received valproate that has little detrimental impact on cognitive function ([@R32], [@R33]). Therefore, we did not find significant correlation between dose of medication and cognitive performance.

Depression and Anxiety {#s3e}
----------------------

Although depression and anxiety were reported as common psychiatric disorders in the patients with epilepsy ([@R34]), the results of BDI scores did not differ between the case and controls, which was in consistent with Kim et al study ([@R30]). Also, the BDI score was not correlated with cognitive performance

Limitations {#s4}
===========

One of the limitations of this study was the lack of functional MRI data of patients which hindered our ability to demonstrate any relationship between localization of epilepsy and cognitive functions. Moreover, it is preferable to investigate patients with epilepsy who are not receiving AED medications, because of adverse effects of AEDs which potentially contribute to cognitive impairment. Finally and in practice, it was not possible to consider a blind examiner for cognitive assessments.

Conclusion {#s5}
==========

In conclusion, this study indicates that JME is associated with impairment in specific cognitive domains and more specifically in the frontal, prefrontal and memory domains. In addition age, education level, duration of disease and medication had an impact on cognitive performance. However more investigation should be performed in the patients with JME to understand the depth and extension of neuropsychological deficits to provide a better clinical care and neuropsychological rehabilitation in the management of this group of patients.

Another important finding of this study is the presence of a relationship between the level of education and the scores of cognitive tests in the patients with JME. It may be claimed that higher level of education may play a role - as a reserve- against cognitive deficits which seemed to be an inevitable consequence in the patients who have to struggle with both epilepsy and the negative impacts of antiepileptic medications on their cognitive functions.

###### 

Characteristics patients with Juvenile Myoclonic Epilepsy (JME) and control cases; mean (SD) or n (%)

                                  JME (n=32)    Controls      *P* values
  ------------------------------- ------------- ------------- ------------
  Age, years                      28.7 (11.4)   33.7 (12.3)   0.100
  Sex, male                       13 (40.6)     17 (53.1)     0.316
  Education                                                   
   Graduated from school          13 (40.6)     19 (59.4)     
   Graduated from university      11 (34.4)     21 (65.6)     
  Family history                  21 (65.6)                   
  Febrile convulsion              6 (18.8)                    
  Duration of epilepsy, years     11.8 (11.4)                 
  Duration of medication, years   8.6 (8.9)                   

###### 

Cognitive performances of patients with Juvenile Myoclonic Epilepsy (JME) and control cases; mean (SD)

                          JME (n=32)     Controls       *P* values
  ----------------------- -------------- -------------- ------------
  **WMS**                                               
   General information    5.9 (0.3)      5.9 (0.3)      0.924
   Orientation            5.0 (0.0)      5.0 (0.3)      0.557
   Mental control         7.2 (1.5)      8.1 (1.2)      0.015
   Logical memory         9.4 (4.2)      10.4 (3.5)     0.344
   Digit span, forward    5.7 (0.7)      6.2 (0.7)      0.004
   Digit span, backward   4.1 (0.6)      4.4 (0.7)      0.082
   Digit span, total      9.8 (1.1)      10.6 (1.2)     0.008
   Visual memory          9.8 (3.3)      11.1 (3.4)     0.159
   Associative learning   17.5 (2.9)     18.0 (4.2)     0.622
   Memory quotient        103.6 (13.3)   110.6 (15.8)   0.059
  **WCST**                                              
   Perseverative errors   8.2 (9.4)      7.5 (10.4)     0.783
  **Stroop**                                            
   Word                   0.3 (0.7)      0.2 (0.5)      0.716
   Color                  2.8 (2.2)      2.3 (2.1)      0.388
  **IQ score**            106.7 (11.8)   115.8 (11.8)   0.003
  **BDI**                 11.4 (8.2)     8.5 (6.8)      0.126

WMS, Wechsler Memory Scale; WCST, Wisconsin Card Sorting Test; BDI, Beck Depression Inventory
